$CAI 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Regulation FD Disclosure Beginning on September 14, 2026, representatives of Caris Life Sciences, Inc. (the “Company”) intend to use an investor presentation (the “Investor Presentation”) in meetings with current and potential investors at the Morgan Stanley 24t...
05 Aug 2026	8-K: Results of Operations and Financial Condition
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
02 Apr 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
26 Feb 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
05 Nov 2025	8-K: Results of Operations and Financial Condition
30 Oct 2025	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
12 Aug 2025	8-K: Results of Operations and Financial Condition
20 Jun 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events

Comments